A carregar...
Monitoring Serum VEGF in Neoadjuvant Chemotherapy for Patients with Triple‐Negative Breast Cancer: A New Strategy for Early Prediction of Treatment Response and Patient Survival
BACKGROUND. This study aimed to investigate the clinical utility of serum biomarker changes during neoadjuvant chemotherapy (NAC) for triple‐negative breast cancer (TNBC). METHODS. A total of 303 patients with TNBC were included in this study. Serum samples were taken at three time points during NAC...
Na minha lista:
| Publicado no: | Oncologist |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Inc.
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6656497/ https://ncbi.nlm.nih.gov/pubmed/30126858 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2017-0602 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|